Abstract
Introduction: Pre-operative breast MRI for the patient with newly diagnosed BC increases the sensitivity of characterising the tumours , tumour size, multifocality-multicentricity, dermal and lymph node involvement. It assesses treatment response and guides treatment planning. Predicting biological subtype using IHC (ER, PR, Her2 neu) has become the standard of care. Very few studies focussing on the comparison between multiparametric MRI and molecular subtypes are available.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
